Navigation Links
New pain relief targets discovered
Date:4/17/2014

Scientists have identified new pain relief targets that could be used to provide relief from chemotherapy-induced pain. BBSRC-funded researchers at King's College London made the discovery when researching how pain occurs in nerves in the periphery of the body.

Dr Marzia Malcangio said: "We have been investigating and identifying mechanisms underlying pain generation and our findings could help chemotherapy patients who suffer pain related side effects."

One potential side effect of some chemotherapy drugs (such as vincristine) is damage to nerves. This is particularly prominent in hands and feet as the drugs affect nerves in the periphery of the body. This causes pain which doctors treat with painkillers. However, some people find that the pain persists.

Dr Malcangio's team investigated why the chemotherapy drugs were causing pain in hope to solve the problem. The used mice in the study because mice given the chemotherapy drug also experienced pain in their nerve extremities (such as their hind-paws).

By studying the mice, they found that the pain was caused by the mouse's own immune system responding to damaged blood vessels.

Dr Marzia Malcangio explained: "The chemotherapy drug was found to cause damage to blood vessels around the nerves. When this happened, immune cells leave the blood flow and enter the nerve to help reduce the inflammation, but they also activate pain. Chemicals released naturally by the immune cells were activating the nerves and producing pain."

To try to prevent the pain, researchers looked at ways of stopping the immune cells entering the nerve. They identified receptors on the outside of the immune cells that could be targeted to stop their exit from blood, constituting new types of pain treatment.

Dr Marzia Malcangio added: "We have discovered that the pain responses are caused by local activation of pain nerves by immune cells and that this could be prevented. Our result can be exploited to produce drugs that, given in combination with treatment, may limit the pain experienced by patients during chemotherapy cycles."

Professor Jackie Hunter, BBSRC Chief Executive said: "This BBSRC CASE studentship has enabled a mutually beneficial research collaboration between academia and industry. Understanding the biological mechanisms of pain, using this mouse model, could lead to new types of pain management."


'/>"/>

Contact: Chris Melvin
chris.melvin@bbsrc.ac.uk
01-793-414-694
Biotechnology and Biological Sciences Research Council
Source:Eurekalert  

Related medicine news :

1. Botox Offers Little Relief for Migraine, Study Finds
2. Study Explores Distractions Role in Pain Relief
3. Spider-Phobes May Get Quick Relief
4. The W3 Project Receives Support from Doulton for Emergency Relief Efforts
5. Deep Brain Stimulation May Offer Longer-Term Relief for Parkinsons
6. Back Pain Relief4Life Announces $47 Program
7. Vygone Introduces A New Zapper For Effective Relief From Herpes Virus Related Skin Problems
8. Relief for Migraine Sufferers as The Life House Offers New Findings, Free Consults
9. Vertebroplasty reportedly provides better pain relief and function
10. Generic drugs key to US overseas HIV relief
11. Standard radiation therapy dose provides pain relief for painful heel spurs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New pain relief targets discovered
(Date:3/29/2017)... Horeb, WI (PRWEB) , ... March 29, 2017 , ... ... patients on early orthodontic treatment and accepting new pediatric patients, with or without a ... help young patients have a better orthodontic outcome and experience. When patients receive early ...
(Date:3/29/2017)... ... March 29, 2017 , ... An inventor ... "The rubber bands used in conjunction with my braces always rubbed against the ... a way to prevent this problem." The O.B.S. was the result of his ...
(Date:3/29/2017)... ... March 29, 2017 , ... Patients ... access to the robotic-assisted total-hip and partial-knee replacement surgeries that are offered ... Forbes Hospital and Jefferson Hospital recently started performing these surgeries using the ...
(Date:3/28/2017)... ... March 28, 2017 , ... A recent Bellwether Education Partners’ ... the field must first improve teacher preparation program design. It then asserts that ... that decades of input- and outcome-based research has failed to improve teacher education. ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, ... be invited to the Siemens Healthineers annual customer education symposium, a world-class learning ... take place from March 27 - 31, 2017 at the Atlanta Marriott Marquis ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017 On March 28, the U.S. Food and Drug ... relapsing forms of multiple sclerosis (MS) and primary progressive ... by the FDA for PPMS. Ocrevus is an intravenous ... "Multiple sclerosis can have a profound impact on ... director of the Division of Neurology Products in the ...
(Date:3/29/2017)... March 29, 2017 /PRNewswire/ - Medicure Inc. ("Medicure") (TSXV:MPH, ... results for the year ended December 31, 2016 ... The results are being released later than the ... will include the operations and balances of Apicore ... This release and filing date meets TSX Venture ...
(Date:3/29/2017)... DUBLIN , Mar. 29, 2017 Research ... Safety and Risk Management Software Market Outlook: 2016-2022" report to ... ... segmented by product, mode of delivery, end-user, and geography. ... healthcare systems across the globe. The field has developed significantly in ...
Breaking Medicine Technology: